Torregrossa Gianluca, Amabile Andrea, Williams Elbert E, Fonceva Ana, Hosseinian Leila, Balkhy Husam H
Division of Cardiac Surgery, Department of Surgery, University of Chicago Medicine, Chicago, Illinois.
Department of Cardiovascular Surgery, Mount Sinai Hospital, New York City, New York.
J Card Surg. 2020 May;35(5):1072-1081. doi: 10.1111/jocs.14537. Epub 2020 Apr 15.
Although abundant biological, clinical, and scientific evidence exists on the superiority of multi-arterial (MAR) and total-arterial revascularization (TAR) over the conventional strategy with a single internal thoracic artery, only 10% of patients undergoing coronary artery bypass grafting (CABG) in the United States receives a second arterial conduit, and only 5% of patients receives TAR.
In January 2020, the authors performed comprehensive search to identify studies that evaluated MAR and TAR strategies through the MEDLINE database.
In this paper, the authors reviewed the literature on the historical and current evidence in favor of MAR and TAR, thus underlying why current CABG practice needs qualitative improvement.
尽管有大量生物学、临床及科学证据表明，多动脉（MAR）和全动脉血运重建（TAR）策略优于使用单一胸廓内动脉的传统策略，但在美国，接受冠状动脉旁路移植术（CABG）的患者中只有10%使用了第二条动脉血管桥，仅有5%的患者接受了TAR。
2020年1月，作者进行了全面检索，以通过MEDLINE数据库识别评估MAR和TAR策略的研究。
在本文中，作者回顾了支持MAR和TAR的历史及当前证据的文献，从而说明了当前CABG实践为何需要质性改进。
